openPR Logo
Press release

Viral Clearance Market on Track to Hit USD 1464.76 Million By 2032, Propelled by an Impressive CAGR of 12.0%

04-01-2024 09:46 AM CET | Health & Medicine

Press release from: Polaris Market Research & Consulting

Viral Clearance Market

Viral Clearance Market

The rising number of new drug releases across various segments and growing demand for pharmaceuticals for treating various conditions are anticipated to drive the demand for viral clearance.

The global viral clearance market was valued at USD 530.34 million in 2023 and is projected to grow to USD 1464.76 million by 2032 at a CAGR of 12.0% during the forecast period of 2024 to 2032.

๐€๐œ๐œ๐ž๐ฌ๐ฌ ๐ญ๐ก๐ž ๐‚๐จ๐ฆ๐ฉ๐ซ๐ž๐ก๐ž๐ง๐ฌ๐ข๐ฏ๐ž ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐‡๐ž๐ซ๐ž! https://www.polarismarketresearch.com/industry-analysis/viral-clearance-market/request-for-sample

Viral contamination is a common threat to both human and animal-derived biopharmaceuticals. This contamination type can come from cell lines or adventitious and affect any part of the bioproduction process.

Viral clearance refers to the process of removing viral contaminants using specialized membranes or chromatography. It is done to ensure that the therapeutic drugs derived from specific sources don't contain any viral contamination. Viral clearance is typically used by pharmaceutical and biotech companies, academic research institutes, and CROs in the development of cellular & gene therapy products, recombinant proteins, blood and blood products, and vaccines.

๐’๐จ๐ฆ๐ž ๐Ž๐Ÿ ๐ญ๐ก๐ž ๐Œ๐š๐ฃ๐จ๐ซ ๐•๐ข๐ซ๐š๐ฅ ๐‚๐ฅ๐ž๐š๐ซ๐š๐ง๐œ๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Š๐ž๐ฒ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ ๐Ž๐ฉ๐ž๐ซ๐š๐ญ๐ข๐ง๐  ๐ˆ๐ง ๐“๐ก๐ž ๐ˆ๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐€๐ซ๐ž:

โ€ข Allure Medical Group
โ€ข Charles River Laboratories
โ€ข Clean Cells
โ€ข Creative Biogene
โ€ข Eurofins Scientific SE
โ€ข Kedrion
โ€ข Labor Dr. Merk & Kollegen GmbH
โ€ข Merck KGaA
โ€ข Microbiologics
โ€ข Sartorius AG
โ€ข Syngene International Limited
โ€ข Texcell
โ€ข ViruSure GmbH
โ€ข Wuxi Biologics

The industry participants are competing on various factors like improving the efficacy of viral clearance, increasing regulatory compliance and diversifying product portfolio.

๐†๐ž๐ญ ๐€๐ก๐ž๐š๐ ๐ฐ๐ข๐ญ๐ก ๐ƒ๐ž๐ญ๐š๐ข๐ฅ๐ž๐ ๐‘๐ž๐ ๐ข๐จ๐ง๐š๐ฅ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ:
https://www.polarismarketresearch.com/buy/3693/2

๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐ƒ๐ซ๐ข๐ฏ๐ž๐ซ๐ฌ:

๐ˆ๐ง๐œ๐ซ๐ž๐š๐ฌ๐ข๐ง๐  ๐ƒ๐ž๐ฆ๐š๐ง๐ ๐Ÿ๐จ๐ซ ๐๐ข๐จ๐ฉ๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ๐ฌ: The growing prevalence of chronic diseases and the development of novel biologics are driving the demand for biopharmaceuticals, thereby fueling the need for effective viral clearance processes.

๐’๐ญ๐ซ๐ข๐ง๐ ๐ž๐ง๐ญ ๐‘๐ž๐ ๐ฎ๐ฅ๐š๐ญ๐จ๐ซ๐ฒ ๐’๐ญ๐š๐ง๐๐š๐ซ๐๐ฌ: Regulatory agencies continue to strengthen requirements for viral safety testing and validation, prompting companies to invest in advanced viral clearance technologies and services to meet compliance standards.

๐€๐๐ฏ๐š๐ง๐œ๐ž๐ฆ๐ž๐ง๐ญ๐ฌ ๐ข๐ง ๐“๐ž๐œ๐ก๐ง๐จ๐ฅ๐จ๐ ๐ฒ: Ongoing research and development efforts are leading to the development of innovative viral clearance technologies, such as chromatography, filtration, and viral inactivation methods, which enhance efficiency and reliability.

๐‘๐ž๐ ๐ข๐จ๐ง๐š๐ฅ ๐‹๐š๐ง๐๐ฌ๐œ๐š๐ฉ๐ž

Among the regional markets, North America dominated the industry owing to the strong presence of major biotechnology firms and medical institutes supporting biotechnology and life science research. Additionally, rising awareness among the population about the use of pharmaceuticals is further supporting the region's development in the market.

๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ฅ ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ

The market segmentation for viral clearance is primarily based on method, application, end-user, and region. By method analysis, the viral clearance segment accounted for the largest industry share owing to its numerous beneficial characteristics, such as high flexibility and efficiency. The CROs segment is projected to grow at a rapid pace as more and more pharmaceutical and biotechnology companies look towards outsourcing their early-phase development services.

๐๐จ๐ฐ ๐ญ๐จ ๐€๐œ๐œ๐ž๐ฌ๐ฌ ๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ-๐ฌ๐ฉ๐ž๐œ๐ข๐Ÿ๐ข๐œ ๐ˆ๐ง๐Ÿ๐จ๐ซ๐ฆ๐š๐ญ๐ข๐จ๐ง, ๐”๐ง๐œ๐จ๐ฏ๐ž๐ซ ๐Š๐ž๐ฒ ๐“๐ซ๐ž๐ง๐๐ฌ, ๐ƒ๐ซ๐ข๐ฏ๐ž๐ซ๐ฌ, ๐š๐ง๐ ๐‘๐ž๐ ๐ข๐จ๐ง๐š๐ฅ ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค! https://www.polarismarketresearch.com/industry-analysis/viral-clearance-market

๐๐จ๐ฅ๐š๐ซ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐ก๐š๐ฌ ๐ฌ๐ž๐ ๐ฆ๐ž๐ง๐ญ๐ž๐ ๐ญ๐ก๐ž ๐ฏ๐ข๐ซ๐š๐ฅ ๐œ๐ฅ๐ž๐š๐ซ๐š๐ง๐œ๐ž ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ ๐›๐š๐ฌ๐ž๐ ๐จ๐ง ๐ฆ๐ž๐ญ๐ก๐จ๐, ๐š๐ฉ๐ฉ๐ฅ๐ข๐œ๐š๐ญ๐ข๐จ๐ง, ๐š๐ง๐ ๐ž๐ง๐-๐ฎ๐ฌ๐ž๐ซ:

๐•๐ข๐ซ๐š๐ฅ ๐‚๐ฅ๐ž๐š๐ซ๐š๐ง๐œ๐ž, ๐Œ๐ž๐ญ๐ก๐จ๐ ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค (๐‘๐ž๐ฏ๐ž๐ง๐ฎ๐ž - ๐”๐’๐ƒ ๐Œ๐ข๐ฅ๐ฅ๐ข๐จ๐ง, ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ— - ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ)

โ€ข Viral Removal Method
โ€ข Viral Inactivation Method
โ€ข Viral Detection Method

๐•๐ข๐ซ๐š๐ฅ ๐‚๐ฅ๐ž๐š๐ซ๐š๐ง๐œ๐ž, ๐€๐ฉ๐ฉ๐ฅ๐ข๐œ๐š๐ญ๐ข๐จ๐ง ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค (๐‘๐ž๐ฏ๐ž๐ง๐ฎ๐ž - ๐”๐’๐ƒ ๐Œ๐ข๐ฅ๐ฅ๐ข๐จ๐ง, ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ— - ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ)

โ€ข Blood and Blood Products
โ€ข Recombinant Proteins
โ€ข Cellular & Gene
โ€ข Therapy Products
โ€ข Vaccines
โ€ข Others

๐•๐ข๐ซ๐š๐ฅ ๐‚๐ฅ๐ž๐š๐ซ๐š๐ง๐œ๐ž, ๐„๐ง๐ ๐”๐ฌ๐ž๐ซ ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค (๐‘๐ž๐ฏ๐ž๐ง๐ฎ๐ž - ๐”๐’๐ƒ ๐Œ๐ข๐ฅ๐ฅ๐ข๐จ๐ง, ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ— - ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ)

โ€ข Pharmaceutical and Biotech Industry
โ€ข Academic Research Institutes
โ€ข CROs
โ€ข Others

๐Œ๐จ๐ซ๐ž ๐“๐ซ๐ž๐ง๐๐ข๐ง๐  ๐‹๐š๐ญ๐ž๐ฌ๐ญ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ ๐›๐ฒ ๐๐จ๐ฅ๐š๐ซ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก:

Power Bank Market: https://www.polarismarketresearch.com/industry-analysis/power-banks-market

A2P Messaging Market: https://www.polarismarketresearch.com/industry-analysis/a2p-messaging-market

Cedarwood Oil Market: https://www.polarismarketresearch.com/industry-analysis/cedarwood-oil-market

Fungal Staining Reagent Market: https://www.polarismarketresearch.com/industry-analysis/fungal-staining-reagent-market

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐ˆ๐ง๐Ÿ๐จ:

Polaris Market Research
Phone: +1-929-297-9727
Email: sales@polarismarketresearch.com

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ:

Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defence, among different ventures present globally.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Viral Clearance Market on Track to Hit USD 1464.76 Million By 2032, Propelled by an Impressive CAGR of 12.0% here

News-ID: 3447169 • Views: โ€ฆ

More Releases from Polaris Market Research & Consulting

Decentralized Workforce Tools Market Size to Hit USD 76.38 Billion by 2034 with a CAGR of 6.8%
Decentralized Workforce Tools Market Size to Hit USD 76.38 Billion by 2034 with โ€ฆ
The decentralized workforce tools market is poised to register a CAGR of 6.8% from 2025 to 2034. The market was valued at USD 39.62 billion in 2024. It is anticipated to grow to USD 76.38 billion by 2034. Market Overview: Decentralized workforce tools refer to technologies and strategies that enable collaboration, communication, and work management within a distributed or remote workforce. These tools allow employees to work effectively across different locationsโ€ฆ
Creator Economy Platforms Market to Reach USD 701.06 Billion by 2034, Growing at a CAGR of 15.8%
Creator Economy Platforms Market to Reach USD 701.06 Billion by 2034, Growing at โ€ฆ
The market for creator economy platforms is poised to witness substantial growth in the coming years, according to the latest research report by Polaris Market Research. The market was valued at USD 161.97 billion in 2024 and is anticipated to grow to USD 701.06 billion by 2034. It is projected to exhibit a compound annual growth rate (CAGR) of 15.8% during 2025-2034. What Are Creator Economy Platforms? Creator economy platforms are digitalโ€ฆ
FinTech Market Poised for Significant Growth Expected to Reach US$ 1,537.93 Billion Driven by an 16.3% CAGR From 2025 to 2034
FinTech Market Poised for Significant Growth Expected to Reach US$ 1,537.93 Bill โ€ฆ
The global fintech market is expected to gain market growth during the forecast period of 2025-2034. Polaris Market Research analyses the market to account for USD 1,537.93 billion by 2034 and is expected to register a CAGR of 16.3% in the above-mentioned forecast period. The market was valued at USD 340.76 billion in 2024. Market Overview: Fintech, short for financial technology, refers to the innovative tools and systems used to perform foundationalโ€ฆ
Protein A Resin Market Soars to US$ 2,832.54 Million Experiencing a 6.4% CAGR Boosted Forecast By 2025 to 2034
Protein A Resin Market Soars to US$ 2,832.54 Million Experiencing a 6.4% CAGR Bo โ€ฆ
According to Polaris Market Research analysis, the global protein A resin market was valued at USD 1,525.00 million in 2024 and is projected to reach USD 2,832.54 million by 2034, registering a compound annual growth rate (CAGR) of 6.4% from 2025-2034. Market Introduction: Protein A resin is an affinity chromatography medium widely used for the efficient purification of monoclonal antibodies (mAbs) and immunoglobulins from cell culture media. In addition to its roleโ€ฆ

All 5 Releases


More Releases for Viral

Viral Inactivation Market Growing Demand of Kits and Reagents Viral Inactivation โ€ฆ
According to Precision Business Insights (PBI), the latest report, the Viral Inactivation market is expected to be worth USD 2.1 billion in 2022, growing at a 12.8% CAGR from 2022 to 2028. The primary driver of the expansion of the global Viral Inactivation market are speedy growth in pharmaceutical and biotechnology industries and strong inclination of R&D investments in life sciences industry. View the detailed report description here - https://precisionbusinessinsights.com/market-reports/viral-inactivation-market/ Kits &โ€ฆ
Global Anti-Viral Drug Therapy Market | Global Anti-Viral Drug Therapy Industry โ€ฆ
Anti-viral drug therapy market comprises of sales of branded & generic anti-viral drugs and related services by entities that manufacture the branded or generic anti-viral drugs for treating microbial infections. Anti-viral drug therapy industry includes several establishments that manufacture anti-viral drugs, which are used to treat diseases caused by viral infections. Examples of antiviral drugs include cidofovir, amantadine, zanamivir, idoxuridine, famiciclovir, tenofovir, adefovir and ribavirin. According to study, โ€œAnti-Viral Drug Therapyโ€ฆ
Viral Antigens Market to Reap Excessive Revenues by 2028(Based on product type, โ€ฆ
Antigens are commonly referred to as substances that are capable of triggering an immune response in a host by activating the lymphocytes or initiating antibody production against infections. Depending upon the fact that they either enter the human body or originate within the body, viral antigens are classified as foreign or self-antigens respectively. Among these, self-antigens comprise mutated or overexpressed proteins. However, foreign antigens are likely to include bacteria, parasites,โ€ฆ
Viral Vector and Plasmid DNA Manufacturing Market - Increase In Awareness Regard โ€ฆ
The Viral Vector and Plasmid DNA Manufacturing Market is expected to reach $ 1,090 million in 2023, growing at an annual average rate of 22.6% from 2017 to 2023. North America was the largest contributor to the viral vector and plasmid DNA markets in 2016. However, the Asia Pacific region is expected to have the highest growth rate during the forecast period. Gene therapy has included tools such as viral vectorsโ€ฆ
Viral Vaccines Market : Challenges and Opportunities Against Viral Diseases
Vaccines are biotic compositions. They are basically formulated from living beings that increase the resistance against a specific illness. Vaccinations that help in avoiding the occurrence of specific diseases are known as prophylactic vaccines and in other instance, the vaccines that are helpful in treating the disease are called therapeutic vaccines. A vaccine is generally produced by using a weakened or murdered type of the sickness causing microorganism. The agentโ€ฆ
Global Viral Molecular Diagnostics Market
The Viral Molecular Diagnostics Market reportprovides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. Molecular diagnostics refers to a technique used to detect and identify the presence of genetic material or proteins associated with a specific health condition or disease. Viral molecular diagnostic helps inโ€ฆ